In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 666 for your search:
Drug:  recombinant interferon alfa
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: HSC-MS-06-0478, OSP-24412, NCT00581425

2.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CAMN107ADE10, 2010-022006-40, NCT01220648

3.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 75
Sponsor:
Protocol IDs: EORTC-40924

4.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 to 79
Sponsor:
Protocol IDs: FRE-FNCLCC-95009, EU-96026

5.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: Pharmaceutical / Industry
Protocol IDs: SPRI-C98-026, SPRI-C98-026-054, SPRI-I98-026

6.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 19 and over
Sponsor: Other
Protocol IDs: 01-002-0601, NCT00205751

7.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 06762004, NCT00420888

8.

Phase: Phase III
Type: Treatment
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: MSKCC-94004, E-2894, NCI-T93-0198D, T93-0198

9.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 65
Sponsor:
Protocol IDs: MRC-LEUK-MYEL-VII, EU-94030, NCT00002599

10.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SPRI-C94-105/I94-105, SCH-C94-105, SCH-I94-105, NCI-V95-0665

11.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: EORTC-30951, NCT00002737

12.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 to 75
Sponsor: Other
Protocol IDs: CDR0000064718, EORTC-18952, NCT00002763

13.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CORIXA-2885-14, RIR-2885-14, YALE-HIC-8666, NCI-V96-0883, NCT00002767

14.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Any age
Sponsor: Other
Protocol IDs: GER-CML-3, EU-95042, NCT00002771

15.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: E-1694, CAN-NCIC-ME9, MDA-DM-E1694, MSKCC-96008, SWOG-9512, CAN-NCIC-E1694, MSKCC-E1694, SWOG-E1694, E1694, ME9

16.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor:
Protocol IDs: WHO-MEL-TRIAL16, EU-95046

17.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 74
Sponsor:
Protocol IDs: FRE-Q93-902-02, EU-96008

18.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 to 59
Sponsor: NCI, Other
Protocol IDs: MDA DM95-121, P30CA016672, NCI-V96-1010, CDR0000065044, NCT00002835

19.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: NCI, Other
Protocol IDs: CDR0000065146, MRC-LEUK-CML-2000, ECOG-E7995, MRC-LEUK-CML-IV, MRC-LEUK-CML-IVa, EU-96029, E7995, NCT00002868

20.

Phase: Phase III
Type: Treatment
Status: Closed
Age: adult
Sponsor:
Protocol IDs: MRC-LEUK-CML-V, EU-96028, NCT00002869

21.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 10 to 70
Sponsor: NCI, Other
Protocol IDs: ID95-196, P30CA016672, MDA-ID-95196, MDA-DM-95196, NCI-G96-1089, CDR0000065188, NCT00002882

22.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Any age
Sponsor:
Protocol IDs: NCRI-AIM-HIGH, EU-96052, UKCCCR-AIM-HIGH, NCT00002892

23.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: ECOG-1495, E1495

24.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 75 and under
Sponsor: Other
Protocol IDs: CNR-TONE-01, EU-97011, NCT00003063

25.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: Other
Protocol IDs: CMLNSG-99, NCI-V97-1349
1     
New Search